Bond M, Rogers G, Peters J, et al. (2012) The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess 16: 1-470.
Deardorff WJ, Feen E and Grossberg GT. (2015) The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease. Drugs Aging 32: 537-547.
Samochocki M, Hoffle A, Fehrenbacher A, et al. (2003) Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J Pharmacol Exp Ther 305: 1024-1036.